Am. J. Respir. Crit. Care Med., Volume 162, Number 2, August 2000, 716-722

Evaluating the Role of Inducible Nitric Oxide Synthase Using a Novel and Selective Inducible Nitric Oxide Synthase Inhibitor in Septic Lung Injury Produced by Cecal Ligation and Puncture

IKU OKAMOTO, MASAYOSHI ABE, KAZUHIKO SHIBATA, NAOMI SHIMIZU, NORIYUKI SAKATA, TAKESHI KATSURAGI, and KEIICHI TANAKA

Departments of Pharmacology, Emergency and Critical Care Medicine, Laboratory of Biodynamics and Pathology, School of Medicine, Fukuoka University, Fukuoka, Japan

We studied the role of inducible nitric oxide synthase (iNOS) in septic lung injury using a novel and selective iNOS inhibitor (a fused piperidine derivative; ONO-1714) following a cecal ligation and puncture (CLP) procedure. All rats that received CLP died within 48 h after the intervention. The subcutaneous injection of ONO-1714 at 0.03 mg/kg every 12 h resulted in a significantly longer survival time than the saline control only when administration was started 12 h after the CLP procedure. The other administration schedules, which started immediately or 6 h after the intervention, did not show any improvement in the survival rates in comparison with the saline control. The administration of ONO-1714 at higher (0.1 mg/ kg) or lower (0.01 mg/kg) doses when given anytime after the intervention did not improve the survival rates. The NO_x (NO₂ + NO₃) levels in the plasma significantly increased 12 h after intervention in comparison with NO_x at 0 h and thereafter further increased in parallel with the time elapsed. The CLP rats that were initially treated with ONO-1714 (0.03 mg/kg subcutaneously every 12 h) 12 h after intervention showed significantly reduced NO_x levels in the plasma in comparison with the saline control. The NO synthase activity in lung homogenates increased from 6 to 24 h after the CLP and thereafter decreased to 42 h. The administration of ONO-1714 inhibited iNOS activity (under calcium-free conditions) in preference to total iNOS activity (under calcium-dependent conditions) in lung homogenates, which thus suggested that this compound selectively inhibited iNOS in lung tissue. The iNOS protein expression in the lung and liver homogenates showed a similar time course with alterations of NOS activity, namely a maximum level at 24 h after the intervention followed by decreasing levels to 42 h. On the other hand, other isozymes of NOS, eNOS, and nNOS in lung homogenates, were constantly expressed over the time course after the CLP. Since the iNOS mRNA expression in lung homogenates continued to elevate until 42 h, the decrease in iNOS activity and protein expression later than 24 h after the CLP was thus considered to be due to some posttranscriptional mechanism during the late phase of sepsis. In conclusion, intervention with a potent and selective iNOS inhibitor seemed to improve survival in CLP rats when used at the appropriate doses and time points. However, the self-limited mechanism of iNOS regulation in the lungs may also indicate that iNOS plays only a limited role in sepsis and septic shock.

This article has been cited by other articles:

				D. Fernandes, R. Sordi, L. K. Pacheco, G. M. Nardi, B. T. Heckert, C. G. Villela, A. R. Lobo, C. Barja-Fidalgo, and J. Assreuy Late, but Not Early, Inhibition of Soluble Guanylate Cyclase Decreases Mortality in a Rat Sepsis Model J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 991 - 999. [Abstract] [Full Text] [PDF]

				J. Zhang, B. Jin, L. Li, E. R. Block, and J. M. Patel Nitric oxide-induced persistent inhibition and nitrosylation of active site cysteine residues of mitochondrial cytochrome-c oxidase in lung endothelial cells Am J Physiol Cell Physiol, April 1, 2005; 288(4): C840 - C849. [Abstract] [Full Text] [PDF]

				H. L. Attalah, S. Honore, S. Eddahibi, E. Marcos, C.-J. Soussy, S. Adnot, and C. Delclaux Decreased exhaled nitric oxide as a marker of postinsult immune paralysis J Appl Physiol, October 1, 2004; 97(4): 1188 - 1194. [Abstract] [Full Text] [PDF]

				L. G. Fischer, J. H. Hilpert, H. Freise, D. Wendholt, H. Van Aken, and A. W. Sielenkamper Bradykinin-Induced Pulmonary Vasoconstriction Is Time and Inducible Nitric Oxide Synthase Dependent in a Peritonitis Sepsis Model Anesth. Analg., September 1, 2004; 99(3): 864 - 871. [Abstract] [Full Text] [PDF]

				J. C. Rudkowski, E. Barreiro, R. Harfouche, P. Goldberg, O. Kishta, P. D'Orleans-Juste, J. Labonte, O. Lesur, and S. N. A. Hussain Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L793 - L800. [Abstract] [Full Text] [PDF]

				R. Hernanz, M. J Alonso, H. Zibrandtsen, Y. Alvarez, M. Salaices, and U. Simonsen Measurements of nitric oxide concentration and hyporeactivity in rat superior mesenteric artery exposed to endotoxin Cardiovasc Res, April 1, 2004; 62(1): 202 - 211. [Abstract] [Full Text] [PDF]

				K. Nagata, Y. Iwasaki, Y. Takemura, H. Harada, I. Yokomura, S. Fushiki, and M. Nakagawa Effect of Inhaled NG-Nitro-L-Arginine Methyl Ester on Candida-Induced Acute Lung Injury Chest, December 1, 2003; 124(6): 2293 - 2301. [Abstract] [Full Text] [PDF]

				K. Mikawa, K. Nishina, Y. Takao, and H. Obara ONO-1714, a Nitric Oxide Synthase Inhibitor, Attenuates Endotoxin-Induced Acute Lung Injury in Rabbits Anesth. Analg., December 1, 2003; 97(6): 1751 - 1755. [Abstract] [Full Text] [PDF]

				W. C. Aird The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome Blood, May 15, 2003; 101(10): 3765 - 3777. [Abstract] [Full Text] [PDF]

				D. Ogawa, K. Shikata, M. Matsuda, S. Okada, H. Usui, J. Wada, N. Taniguchi, and H. Makino Protective effect of a novel and selective inhibitor of inducible nitric oxide synthase on experimental crescentic glomerulonephritis in WKY rats Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2117 - 2121. [Abstract] [Full Text] [PDF]

				J. Zhang, S.-L. Xia, E. R. Block, and J. M. Patel NO upregulation of a cyclic nucleotide-gated channel contributes to calcium elevation in endothelial cells Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1080 - C1089. [Abstract] [Full Text] [PDF]

				D.A. Kregenow and E.R. Swenson The lung and carbon dioxide: implications for permissive and therapeutic hypercapnia Eur. Respir. J., July 1, 2002; 20(1): 6 - 11. [Full Text] [PDF]

				L. F. Wang, M. Patel, H. M. Razavi, S. Weicker, M. G. Joseph, D. G. McCormack, and S. Mehta Role of Inducible Nitric Oxide Synthase in Pulmonary Microvascular Protein Leak in Murine Sepsis Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1634 - 1639. [Abstract] [Full Text] [PDF]

				J. A. Scott, S. Mehta, M. Duggan, A. Bihari, and D. G. McCormack Functional Inhibition of Constitutive Nitric Oxide Synthase in a Rat Model of Sepsis Am. J. Respir. Crit. Care Med., May 15, 2002; 165(10): 1426 - 1432. [Abstract] [Full Text] [PDF]

				B. R. Pitt and C. M. St. Croix Complex Regulation of iNOS in Lung Am. J. Respir. Cell Mol. Biol., January 1, 2002; 26(1): 6 - 9. [Full Text] [PDF]

				M. J. TOBIN Critical Care Medicine in AJRCCM 2000 Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1347 - 1361. [Full Text] [PDF]